原発性乳腺リンパ腫:乳癌患者における稀だが重要な鑑別診断
Irappa Madabhavi1,2,3, Malay Sarkar4, Raghavendra Sagar5
1Department of Medical and Pediatric Oncology and Hematology, J. N. Medical College and KLE Academy of Higher Education and Research, Belagavi, Karnataka, India.
Abstract:
This report is based upon the case of a young lady who presented with a history of a breast lump, which despite clinically resembling a carcinoma, was subsequently diagnosed to be a primary breast lymphoma (PBL). Though rare in incidence, PBL may masquerade as breast carcinoma. PBL accounts for about 1.7-2.2% of all extranodal non-Hodgkin's lymphoma, and is accountable for up to 0.5% of all breast malignancies. Given that the treatments of breast carcinoma and PBL are markedly different, it is very essential that core-biopsy be preferred in every patient being evaluated for carcinoma of the breast. The diagnosis of diffuse large B cell lymphoma (DLBCL) was confirmed by immunohistochemistry, and the patient has been treated with six-cycles of chemotherapy followed by involved field-radiotherapy to the right breast. After a year's follow-up, the patient remains free of disease.
さらに関連する動画
07:51The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
